'MBB Depth Without the MBB Team' Is Half an Answer

If you run a boutique advisory practice, your inbox has probably filled up this year with a specific pitch. It goes: get McKinsey-grade research depth without the McKinsey-sized team, white-labeled under your brand, in days instead of weeks.

It's a good pitch, and the striking thing is how many credible companies are now making it. Elevated Signal offers consultants "McKinsey-depth research without the McKinsey-sized research team," delivered in forty-eight hours instead of four weeks, under the firm's own brand. 13research runs competitive intelligence and desk research in two to five business days, with no retainer and no headcount, explicitly positioned against the $80,000-to-$120,000 cost of an in-house analyst. Commercial IQ delivers MBB-quality analytics at roughly a third of onshore cost. And the underlying model isn't fringe: DiligenceSquared, which produces for around $50,000 the kind of diligence the big firms charge $500,000 to a million for, raised institutional venture money on exactly this thesis.

I want to be clear before the turn: this is real, and it's good. If you're a solo advisor doing your synthesis at 11pm because there's no one else to hand it to, managed research capacity is a genuine relief. The capacity is no longer the bottleneck it was.

What the pitch quietly assumes

Here's the assumption buried in "MBB depth without the MBB team": that the hard, scarce part of the work is producing the research. For a long time it was. It isn't anymore, which is the whole reason these companies can exist. When a dozen vendors can turn a document pile into a competitive landscape in forty-eight hours, that landscape is no longer a differentiator. It's a commodity, and commodities compete on price and speed – which is exactly what all of those pages lead with.

The part that doesn't commoditize is the part none of them are selling: the synthesis that someone puts their name on. A research feed can tell you what the market is doing. It cannot tell your client which of those facts should change their decision, and it cannot answer for that call when the client asks. That judgment – reading the pile and saying this is the thing that matters, this is the risk you're not pricing in – is the work a client actually pays a boutique advisor for. The rest is input to it.

The name on it is the value

There's a reason a free tool's answer is worth less than the same answer from a person, even when the words are identical. The tool has no reputation to lose. Its confidence costs it nothing, so its confidence is worth nothing. A person who signs a recommendation is putting something at stake, and that stake is most of what the client is buying – not the research, the accountability for the read of it.

For an advisor, that flips the usual framing of these services. The right way to use managed research isn't to outsource the thinking; it's to take the 70% that's genuinely mechanical off your plate so you can spend your hours on the 30% that is only yours. Tiffany Haynes of Illumea Advisory runs document-heavy engagements this way – the reading and cross-referencing for a client of hers, a payments technology company, come back most of the way done, and she layers in the strategic context and the client judgment and presents it as her own. Because it is her own. The pipeline did the synthesis; she did the part the client is paying Illumea, and not a research vendor, to do.

That's the line I'd hold if I were evaluating one of these offers. Buy the capacity. It's real and it's worth it. Just don't confuse it with the job. The vendors are selling you the 70%, priced and delivered beautifully. The 30% they can't sell is the practice – and it's the only half that was ever really yours.